Erlotinib is used in the treatment of non-small cell lung cancer and pancreatic cancer.

Erlotinib is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

Nausea, Vomiting, Fatigue, Breathing difficulty, Abdominal pain, Edema, Weight loss, Loss of appetite, Anemia, Infection, Bone pain, Constipation, Diarrhoea, Fever, Stomatitis (Inflammation of the mouth), Rash

• Erlotinib tablets should be taken either 1 hour before or 2 hours after ingestion of food.
• Erlotinib is not recommended for children and adolescents under 18 years of age.
• Stop smoking and use effective contraceptive measures while on erlotinib treatment.
• Do not start erlotinib if you use contact lenses, have had eye problems (ulcers in front part of eye, dry eyes, inflammation in front part of eye), liver or kidney problems, Gilbert’s syndrome (liver disorder that causes increased bilirubin), intolerance to some sugars, are pregnant or breast-feeding.
• Tell your doctor if you suffer from breathing difficulty associated with fever or cough, severe diarrhea, loss of appetite, nausea or vomiting, severe blistering or peeling of skin, severe pain in abdomen, acute or increasing pain and redness in eye, blurred vision or sensitivity to light, increased eye watering.

Ques. Q. Is Erlotinib FDA approved?
Yes, Erlotinib is approved by FDA

Ques. Q. How long does Erlotinib work?
A single dose of Erlotinib works for around 36 hours.

Ques. Q. Is Erlotinib cytotoxic, chemotherapeutic drug, biologic or monoclonal antibody?
Erlotinib is not a cytotoxic, chemotherapy drug, or monoclonal antibody. Erlotinib is a biologic tyrosine kinase inhibitor

Ques. Q. Does Erlotinib cause neutropenia?
Yes, Erlotinib can cause neutropenia